Reckitt Benckiser Plc ADR RBGLY

$16.67 +0.21 (1.28%)

Valuation

Market cap
56,002,380,000
Revenue TTM
$18,106,560,000
Net income TTM
$1,822,290,000
PE ratio
0.00
Forward PE
16.30
Profit margin
10.06%
Debt to equity
1.46

Trading

Volume
186,700
Avg volume
354,946
Day's range
$16.59 – $16.75
Shares out
3,359,471,000
Stochastic %K
88%
Beta
0.39
Analysts
Sell
Price target
$15.05

Price

Company profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names;...

Show more

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Industry
Household & Personal Products
Sector
Consumer Defensive
Phone
44 17 5321 7800
Website
https://www.reckitt.com
Address
Turner House, 103-105 Bath Road, Slough, United Kingdom

Latest news

No headlines yet.